SARS-CoV-2 S1 Monoclonal antibody
To Order Contact us: stephen@expresspharmapulse.com
, Recombinant) Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant |
|||
| P1531-50 | Biovision | 50 µg | Ask for price |
) Recombinant Coronavirus Spike Protein (SARS-CoV S1; His tag) |
|||
| P1516-10 | Biovision | 10µg | EUR 257 |
 SARS CoV-2 PCR kit |
|||
| PCR-H731-48R | Bioingentech | 48T | EUR 823 |
SARS CoV-2 PCR kit |
|||
| PCR-H731-96R | Bioingentech | 96T | EUR 1113 |
, Recombinant) Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S1), Recombinant |
|||
| P1524-10 | Biovision | 10 µg | EUR 277 |
 SARS S1 [His] |
|||
| DAG1861 | Creative Diagnostics | 500 ug | EUR 2529 |
, Recombinant) Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant |
|||
| P1532-10 | Biovision | 10 µg | EUR 156 |
Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant |
|||
| P1532-50 | Biovision | 50 µg | EUR 551 |
 SARS CoV E Protein |
|||
| abx060650-1mg | Abbexa | 1 mg | EUR 1692 |
 SARS CoV Nucleocapsid Protein |
|||
| abx060652-1mg | Abbexa | 1 mg | EUR 1873 |
 SARS-CoV Nucleocapsid Protein |
|||
| abx060653-1mg | Abbexa | 1 mg | EUR 1692 |
SARS-CoV Nucleocapsid Protein |
|||
| abx060654-1mg | Abbexa | 1 mg | EUR 1692 |
 SARS-CoV Spike Protein |
|||
| abx060655-1mg | Abbexa | 1 mg | EUR 1692 |
 SARS-CoV spike protein Antibody |
|||
| abx023139-100ug | Abbexa | 100 ug | EUR 857 |
SARS-CoV spike protein Antibody |
|||
| abx023143-100ug | Abbexa | 100 ug | EUR 857 |
 SARS-CoV-2 IgG ELISA Kit |
|||
| E4901-100 | Biovision | 100 assays | EUR 753 |
) Recombinant Coronavirus Nucleoprotein (SARS-CoV-2) |
|||
| P1523-10 | Biovision | 10 µg | EUR 156 |
Recombinant Coronavirus Nucleoprotein (SARS-CoV-2) |
|||
| P1523-50 | Biovision | 50 µg | EUR 551 |
 SARS CoV-2 RT PCR kit |
|||
| RTq-H731-100R | Bioingentech | 100T | EUR 1311 |
SARS CoV-2 RT PCR kit |
|||
| RTq-H731-150R | Bioingentech | 150T | EUR 1787 |
SARS CoV-2 RT PCR kit |
|||
| RTq-H731-50R | Bioingentech | 50T | EUR 963 |
 SARS-CoV-2 Antigen ELISA Kit |
|||
| DEIA2020 | Creative Diagnostics | 96 tests | EUR 905 |
|
Description: SARS-CoV-2 Antigen ELISA Kit intended use is for quantitative detection of the recombinant SARS-COV-2 nucleoprotein antigen in human serum. The use of this kit for natural samples need to be validated by the end user due to the complexity of natural targets and unpredictable interference. |
|||
) Anti-SARS-CoV-2 Antibody (Clone# 6F10) |
|||
| A2060-50 | Biovision | 50 µg | EUR 480 |
) Anti-SARS-CoV-2 NP Antibody (Clone# 11D5) |
|||
| A2092-50 | Biovision | 50 µg | EUR 480 |
) Anti-SARS-CoV-2 NP Antibody (Clone# 4G1) |
|||
| A2093-50 | Biovision | 50 µg | EUR 480 |
 SARS-CoV-2 Nucleoprotein IgG Antibody ELISA Kit |
|||
| E4821-100 | Biovision | 96 assays | EUR 1057 |
) Recombinant SARS-CoV-2 Nucleoprotein (1-430) |
|||
| P1537-10 | Biovision | 10 µg | EUR 156 |
Recombinant SARS-CoV-2 Nucleoprotein (1-430) |
|||
| P1537-50 | Biovision | 50 µg | EUR 530 |
Recombinant SARS-CoV-2 Nucleoprotein (1-430) |
|||
| P1539-10 | Biovision | 10 µg | EUR 156 |
Recombinant SARS-CoV-2 Nucleoprotein (1-430) |
|||
| P1539-50 | Biovision | 50 µg | EUR 530 |
 Recombinant SARS-CoV-2 3C-like Proteinase |
|||
| P1550-10 | Biovision | 10 μg | EUR 156 |
Recombinant SARS-CoV-2 3C-like Proteinase |
|||
| P1550-50 | Biovision | 50 μg | EUR 551 |
 Recombinant SARS-CoV-2 Papain-like Protease |
|||
| P1551-10 | Biovision | 10 μg | EUR 156 |
Recombinant SARS-CoV-2 Papain-like Protease |
|||
| P1551-50 | Biovision | 50 μg | EUR 551 |
 PCR Detection Kit) Coronavirus (SARS-CoV-2) PCR Detection Kit |
|||
| K1460-100 | Biovision | 100 Rxns | Ask for price |
 SARS-CoV-2 Antigen Rapid Test Kit |
|||
| CoV2Ag-1 | UnScience | 1T | EUR 8 |
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
|||
 SARS-CoV-2 Rapid Antigen Test Nasal |
|||
| 9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 94 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
|||